References
- Abeyagunawardena, A. S., & Trompeter, R. S. (2008). Increasing the dose of prednisolone during viral infections reduces the risk of relapse in nephrotic syndrome: A randomised controlled trial. Archives of Disease in Childhood, 93(3), 226–228. https://doi.org/https://doi.org/10.1136/adc.2007.116079
- Abraham, M. J., Murtola, T., Schulz, R., Páll, S., Smith, J. C., Hess, B., & Lindahl, E. (2015). GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX, 1–2, 19–25. https://doi.org/https://doi.org/10.1016/j.softx.2015.06.001
- Alberti, C., Cartier, L., Valenzuela, M. A., Puente, J., Tanaka, Y., & Ramirez, E. (2011). Molecular and clinical effects of betamethasone in human T-cell lymphotropic virus type-I-associated myelopathy/tropical spastic paraparesis patients. Journal of Medical Virology, 83(9), 1641–1649. https://doi.org/https://doi.org/10.1002/jmv.22131
- Anand, K., Ziebuhr, J., Wadhwani, P., Mesters, J. R., & Hilgenfeld, R. (2003). Coronavirus main proteinase (3CLpro) structure: Basis for design of anti-SARS drugs. Science (New York, N.Y.), 300(5626), 1763–1767. https://doi.org/https://doi.org/10.1126/science.1085658
- Arabi, Y. M., Mandourah, Y., Al-Hameed, F., Sindi, A. A., Almekhlafi, G. A., Hussein, M. A., Jose, J., Pinto, R., Al-Omari, A., Kharaba, A., Almotairi, A., Al Khatib, K., Alraddadi, B., Shalhoub, S., Abdulmomen, A., Qushmaq, I., Mady, A., Solaiman, O., Al-Aithan, A. M., Fowler, R. A., … Saudi Critical Care Trial, G (2018). Corticosteroid therapy for critically Ill patients with middle east respiratory syndrome. American Journal of Respiratory and Critical Care Medicine, 197(6), 757–767. https://doi.org/https://doi.org/10.1164/rccm.201706-1172OC
- Baby, K., Maity, S., Mehta, C. H., Suresh, A., Nayak, U. Y., & Nayak, Y. (2020). Targeting SARS-CoV-2 main protease: A computational drug repurposing study. Archives of Medical Research. https://doi.org/https://doi.org/10.1016/j.arcmed.2020.09.013
- Barnes, P. J. (2006). How corticosteroids control inflammation: Quintiles Prize Lecture 2005. British Journal of Pharmacology, 148(3), 245–254. https://doi.org/https://doi.org/10.1038/sj.bjp.0706736
- Beck, B. R., Shin, B., Choi, Y., Park, S., & Kang, K. (2020). Predicting commercially available antiviral drugs that may act on the novel coronavirus (SARS-CoV-2) through a drug-target interaction deep learning model. Computational and Structural Biotechnology Journal., 18, 784–790. https://doi.org/https://doi.org/10.1016/j.csbj.2020.03.025
- Berendsen, H. J. C., Postma, J. P. M., Gunsteren, W. F. v., DiNola, A., & Haak, J. R. (1984). Molecular dynamics with coupling to an external bath. The Journal of Chemical Physics, 81(8), 3684–3690. https://doi.org/https://doi.org/10.1063/1.448118
- Bharadwaj, S., Lee, K. E., Dwivedi, V. D., & Kang, S. G. (2020). Computational insights into tetracyclines as inhibitors against SARS-CoV-2 Mpro via combinatorial molecular simulation calculations. Life Sciences, 257, 118080. https://doi.org/https://doi.org/10.1016/j.lfs.2020.118080
- Bhardwaj, V. K., Singh, R., Sharma, J., Rajendran, V., Purohit, R., & Kumar, S. (2020). Identification of bioactive molecules from tea plant as SARS-CoV-2 main protease inhibitors. Journal of Biomolecular Structure and Dynamics, 1–10. https://doi.org/https://doi.org/10.1080/07391102.2020.1766572
- Biovia, D. S. (2017). Discovery studio modeling environment [Release 4]. San Diego: Dassault Systemes.
- Blanchard, J. E., Elowe, N. H., Huitema, C., Fortin, P. D., Cechetto, J. D., Eltis, L. D., & Brown, E. D. (2004). High-throughput screening identifies inhibitors of the SARS coronavirus main proteinase. Chemistry & Biology, 11(10), 1445–1453. https://doi.org/https://doi.org/10.1016/j.chembiol.2004.08.011
- Cascella, M., Rajnik, M., Cuomo, A., Dulebohn, S. C., Di Napoli, R. (2020). Features, evaluation and treatment coronavirus (COVID-19) (StatPearls). Bethesda, MD: National Center for Biotechnology Information, U.S. National Library of Medicine. http://www.ncbi.nlm.nih.gov/pubmed/32150360
- Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., Qiu, Y., Wang, J., Liu, Y., Wei, Y., Xia, J., Yu, T., Zhang, X., & Zhang, L. (2020). Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study. Lancet (London, England), 395(10223), 507–513. https://doi.org/https://doi.org/10.1016/S0140-6736(20)30211-7
- Chou, K. C., Wei, D. Q., & Zhong, W. Z. (2003). Binding mechanism of coronavirus main proteinase with ligands and its implication to drug design against SARS. Biochemical and Biophysical Research Communications, 308(1), 148–151. https://doi.org/https://doi.org/10.1016/S0006-291X(03)01342-1
- Clement, C., Capriotti, J. A., Kumar, M., Hobden, J. A., Foster, T. P., Bhattacharjee, P. S., Thompson, H. W., Mahmud, R., Liang, B., & Hill, J. M. (2011). Clinical and antiviral efficacy of an ophthalmic formulation of dexamethasone povidone-iodine in a rabbit model of adenoviral keratoconjunctivitis. Investigative Ophthalmology & Visual Science, 52(1), 339–344. https://doi.org/https://doi.org/10.1167/iovs.10-5944
- Confalonieri, M., Cifaldi, R., Dreas, L., Viviani, M., Biolo, M., & Gabrielli, M. (2010). Methylprednisolone infusion for life-threatening H1N1-virus infection. Therapeutic Advances in Respiratory Disease, 4(4), 233–237. https://doi.org/https://doi.org/10.1177/1753465810376951
- Cucinotta, D., & Vanelli, M. (2020). WHO declares COVID-19 a pandemic. Acta Bio-Medica: Atenei Parmensis, 91(1), 157–160. https://doi.org/https://doi.org/10.23750/abm.v91i1.9397
- Dai, W., Zhang, B., Jiang, X. M., Su, H., Li, J., Zhao, Y., Xie, X., Jin, Z., Peng, J., Liu, F., Li, C., Li, Y., Bai, F., Wang, H., Cheng, X., Cen, X., Hu, S., Yang, X., Wang, J., … Liu, H. (2020). Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease. Science (New York, N.Y.), 368(6497), 1331–1335. https://doi.org/https://doi.org/10.1126/science.abb4489
- Das, S., Sarmah, S., Lyndem, S., & Singha Roy, A. (2020). An investigation into the identification of potential inhibitors of SARS-CoV-2 main protease using molecular docking study. Journal of Biomolecular Structure and Dynamics, 1–11. https://doi.org/https://doi.org/10.1080/07391102.2020.1763201
- Dobson, J., Whitley, R. J., Pocock, S., & Monto, A. S. (2015). Oseltamivir treatment for influenza in adults: A meta-analysis of randomised controlled trials. The Lancet, 385(9979), 1729–1737. https://doi.org/https://doi.org/10.1016/S0140-6736(14)62449-1
- Emery, V. C., Cope, A. V., Sabin, C. A., Burroughs, A. K., Rolles, K., Lazzarotto, T., Landini, M. P., Brojanac, S., Wise, J., & Maine, G. T. (2000). Relationship between IgM antibody to human cytomegalovirus, virus load, donor and recipient serostatus, and administration of methylprednisolone as risk factors for cytomegalovirus disease after liver transplantation. The Journal of Infectious Diseases, 182(6), 1610–1615. https://doi.org/https://doi.org/10.1086/317636
- Essmann, U., Perera, L., Berkowitz, M. L., Darden, T., Lee, H., & Pedersen, L. G. (1995). A smooth particle mesh Ewald method. The Journal of Chemical Physics, 103(19), 8577–8593. https://doi.org/https://doi.org/10.1063/1.470117
- Frisch, M., Clemente, F., Frisch, M. J., Trucks, G. W., Schlegel, H. B., Scuseria, G. E., Robb, M. A., Cheeseman, J. R., Scalmani, G., Barone, V., Mennucci, B., Petersson, G. A., Nakatsuji, H., Caricato, M., Li, X., Hratchian, H. P., Izmaylov, A. F., Bloino, J., & Zhe, G. 2009. Gaussian 09, Revision A. 01. Wallingford CT: Gaussian, Inc.
- Gagyor, I., Madhok, V. B., Daly, F., & Sullivan, F. (2019). Antiviral treatment for Bell's palsy (idiopathic facial paralysis). Cochrane Database of Systematic Reviews, 9 (9), CD001869. https://doi.org/https://doi.org/10.1002/14651858.CD001869.pub9
- Ghosh, R., Chakraborty, A., Biswas, A., & Chowdhuri, S. (2020a). Evaluation of green tea polyphenols as novel corona virus (SARS CoV-2) main protease (Mpro) inhibitors – An in silico docking and molecular dynamics simulation study. Journal of Biomolecular Structure and Dynamics, 1–13. https://doi.org/https://doi.org/10.1080/07391102.2020.1779818
- Ghosh, R., Chakraborty, A., Biswas, A., & Chowdhuri, S. (2020b). Identification of polyphenols from Broussonetia papyrifera as SARS CoV-2 main protease inhibitors using in silico docking and molecular dynamics simulation approaches. Journal of Biomolecular Structure and Dynamics, 1–14. https://doi.org/https://doi.org/10.1080/07391102.2020.1802347
- Gorla, U. S., Rao, G. K., Kulandaivelu, U. S., Alavala, R. R., & Panda, S. P. (2020). Lead finding from selected flavonoids with antiviral (SARS-CoV-2) potentials against COVID-19: An in-silico evaluation. Combinatorial Chemistry & High Throughput Screening. https://doi.org/https://doi.org/10.2174/1386207323999200818162706
- Grum-Tokars, V., Ratia, K., Begaye, A., Baker, S. C., & Mesecar, A. D. (2008). Evaluating the 3C-like protease activity of SARS-Coronavirus: Recommendations for standardized assays for drug discovery. Virus Research, 133(1), 63–73. https://doi.org/https://doi.org/10.1016/j.virusres.2007.02.015
- Guan, W. J., Ni, Z. Y., Hu, Y., Liang, W. H., Ou, C. Q., He, J. X., Liu, L., Shan, H., Lei, C. L., Hui, D. S. C., Du, B., Li, L. J., Zeng, G., Yuen, K. Y., Chen, R. C., Tang, C. L., Wang, T., Chen, P. Y., Xiang, J., … China Medical Treatment Expert Group For, C, China Medical Treatment Expert Group for Covid-19 (2020). Clinical characteristics of coronavirus disease 2019 in China. The New England Journal of Medicine, 382(18), 1708–1720. https://doi.org/https://doi.org/10.1056/NEJMoa2002032
- Gurung, A. B., Ali, M. A., Lee, J., Farah, M. A., & Al-Anazi, K. M. (2020). Unravelling lead antiviral phytochemicals for the inhibition of SARS-CoV-2 Mpro enzyme through in silico approach. Life Sciences, 255, 117831. https://doi.org/https://doi.org/10.1016/j.lfs.2020.117831
- Hage-Melim, L., Federico, L. B., de Oliveira, N. K. S., Francisco, V. C. C., Correia, L. C., de Lima, H. B., Gomes, S. Q., Barcelos, M. P., Francischini, I. A. G., & da Silva, C. (2020). Virtual screening, ADME/Tox predictions and the drug repurposing concept for future use of old drugs against the COVID-19. Life Sciences, 256, 117963. https://doi.org/https://doi.org/10.1016/j.lfs.2020.117963
- Hakmi, M., Bouricha, E. M., Kandoussi, I., Harti, J. E., & Ibrahimi, A. (2020). Repurposing of known anti-virals as potential inhibitors for SARS-CoV-2 main protease using molecular docking analysis. Bioinformation, 16(4), 301–306. https://doi.org/https://doi.org/10.6026/97320630016301
- Harcourt, B. H., Jukneliene, D., Kanjanahaluethai, A., Bechill, J., Severson, K. M., Smith, C. M., Rota, P. A., & Baker, S. C. (2004). Identification of severe acute respiratory syndrome coronavirus replicase products and characterization of papain-like protease activity. Journal of Virology, 78(24), 13600–13612. https://doi.org/https://doi.org/10.1128/JVI.78.24.13600-13612.2004
- Henzi, I., Walder, B., & Tramer, M. R. (2000). Dexamethasone for the prevention of postoperative nausea and vomiting: A quantitative systematic review. Anesthesia and Analgesia, 90(1), 186–194. https://doi.org/https://doi.org/10.1097/00000539-200001000-00038
- Hess, B., Bekker, H., Berendsen, H. J. C., & Fraaije, J. G. E. M. (1997). LINCS: A linear constraint solver for molecular simulations. Journal of Computational Chemistry, 18(12), 1463–1472. https://doi.org/https://doi.org/10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H
- Hodos, R. A., Kidd, B. A., Shameer, K., Readhead, B. P., & Dudley, J. T. (2016). In silico methods for drug repurposing and pharmacology. Wiley Interdisciplinary Reviews. Systems Biology and Medicine, 8(3), 186–210. https://doi.org/https://doi.org/10.1002/wsbm.1337
- Horby, P., Lim, W. S., Emberson, J., Mafham, M., Bell, J., Linsell, L., Staplin, N., Brightling, C., Ustianowski, A., Elmahi, E., Prudon, B., Green, C., Felton, T., Chadwick, D., Rege, K., Fegan, C., Chappell, L. C., Faust, S. N., Jaki, T., … Landray, M. J. (2020). Effect of Dexamethasone in Hospitalized Patients with COVID-19: Preliminary Report. medRxiv, https://doi.org/https://doi.org/10.1101/2020.06.22.20137273
- Hsu, M. F., Kuo, C. J., Chang, K. T., Chang, H. C., Chou, C. C., Ko, T. P., Shr, H. L., Chang, G. G., Wang, A. H., & Liang, P. H. (2005). Mechanism of the maturation process of SARS-CoV 3CL protease. The Journal of Biological Chemistry, 280(35), 31257–31266. https://doi.org/https://doi.org/10.1074/jbc.M502577200
- Islam, R., Parves, M. R., Paul, A. S., Uddin, N., Rahman, M. S., Mamun, A. A., Hossain, M. N., Ali, M. A., & Halim, M. A. (2020). A molecular modeling approach to identify effective antiviral phytochemicals against the main protease of SARS-CoV-2. Journal of Biomolecular Structure and Dynamics, 1–12. https://doi.org/https://doi.org/10.1080/07391102.2020.1761883
- Jimenez-Alberto, A., Ribas-Aparicio, R. M., Aparicio-Ozores, G., & Castelan-Vega, J. A. (2020). Virtual screening of approved drugs as potential SARS-CoV-2 main protease inhibitors. Computational Biology and Chemistry, 88, 107325. https://doi.org/https://doi.org/10.1016/j.compbiolchem.2020.107325
- Jin, Z., Du, X., Xu, Y., Deng, Y., Liu, M., Zhao, Y., Zhang, B., Li, X., Zhang, L., Peng, C., Duan, Y., Yu, J., Wang, L., Yang, K., Liu, F., Jiang, R., Yang, X., You, T., Liu, X., … Yang, H. (2020). Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors. Nature, 582(7811), 289–293. https://doi.org/https://doi.org/10.1038/s41586-020-2223-y
- Joshi, T., Joshi, T., Sharma, P., Mathpal, S., Pundir, H., Bhatt, V., & Chandra, S. (2020a). In silico screening of natural compounds against COVID-19 by targeting Mpro and ACE2 using molecular docking. European Review for Medical and Pharmacological Sciences, 24(8), 4529–4536. https://doi.org/https://doi.org/10.26355/eurrev_202004_21036
- Joshi, T., Sharma, P., Joshi, T., Pundir, H., Mathpal, S., & Chandra, S. (2020b). Structure-based screening of novel lichen compounds against SARS Coronavirus main protease (Mpro) as potentials inhibitors of COVID-19. Mol Divers, https://doi.org/https://doi.org/10.1007/s11030-020-10118-x
- Kandeel, M., & Al-Nazawi, M. (2020). Virtual screening and repurposing of FDA approved drugs against COVID-19 main protease. Life Sciences, 251, 117627. https://doi.org/https://doi.org/10.1016/j.lfs.2020.117627
- Kilbourne, E. D. (1957). The influence of cortisone on experimental viral infection. IV. Negation of interference as the mechanism by which cortisone induces increased virus yields. Journal of Experimental Medicine, 106(6), 863–881. https://doi.org/https://doi.org/10.1084/jem.106.6.863
- Kim, Y., Liu, H., Galasiti Kankanamalage, A. C., Weerasekara, S., Hua, D. H., Groutas, W. C., Chang, K. O., & Pedersen, N. C. (2016). Reversal of the progression of fatal coronavirus infection in cats by a broad-spectrum coronavirus protease inhibitor. PLoS Pathogens, 12(3), e1005531. https://doi.org/https://doi.org/10.1371/journal.ppat.1005531
- Kumar, Y., Singh, H., & Patel, C. N. (2020). In silico prediction of potential inhibitors for the main protease of SARS-CoV-2 using molecular docking and dynamics simulation based drug-repurposing. Journal of Infection and Public Health, 13(9), 1210–1223. https://doi.org/https://doi.org/10.1016/j.jiph.2020.06.016
- Liu, H., Li, J., Chen, M., & Su, J. (2019). Glucocorticoid treatment of suspected organizing pneumonia after H7N9 infection: A case report. Medicine, 98(34), e16839. https://doi.org/https://doi.org/10.1097/MD.0000000000016839
- Lv, Z., Chu, Y., & Wang, Y. (2015). HIV protease inhibitors: A review of molecular selectivity and toxicity. HIV/AIDS (Auckland, N.Z.), 7, 95–104. https://doi.org/https://doi.org/10.2147/HIV.S79956
- Marra, M. A., Jones, S. J., Astell, C. R., Holt, R. A., Brooks-Wilson, A., Butterfield, Y. S., Khattra, J., Asano, J. K., Barber, S. A., Chan, S. Y., Cloutier, A., Coughlin, S. M., Freeman, D., Girn, N., Griffith, O. L., Leach, S. R., Mayo, M., McDonald, H., Montgomery, S. B., … Roper, R. L. (2003). The Genome sequence of the SARS-associated coronavirus. Science (New York, N.Y.), 300(5624), 1399–1404. https://doi.org/https://doi.org/10.1126/science.1085953
- Mazzini, S., Musso, L., Dallavalle, S., & Artali, R. (2020). Putative SARS-CoV-2 M(pro) inhibitors from an in-house library of natural and nature-inspired products: A virtual screening and molecular docking study. Molecules, 25(16), 3745. https://doi.org/https://doi.org/10.3390/molecules25163745
- Mercorelli, B., Palu, G., & Loregian, A. (2018). Drug repurposing for viral infectious diseases: How far are we? Trends in Microbiology, 26(10), 865–876. https://doi.org/https://doi.org/10.1016/j.tim.2018.04.004
- Miyamoto, S., & Kollman, P. A. (1992). Settle: An analytical version of the SHAKE and RATTLE algorithm for rigid water models. Journal of Computational Chemistry, 13(8), 952–962. https://doi.org/https://doi.org/10.1002/jcc.540130805
- Morris, G. M., Huey, R., Lindstrom, W., Sanner, M. F., Belew, R. K., Goodsell, D. S., & Olson, A. J. (2009). AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. Journal of Computational Chemistry, 30(16), 2785–2791. https://doi.org/https://doi.org/10.1002/jcc.21256
- Morris, G. M., Huey, R., & Olson, A. J. (2008). Using AutoDock for ligand-receptor docking. Current Protocols in Bioinformatics, 24(1), 8.14.1–8.14.40. https://doi.org/https://doi.org/10.1002/0471250953.bi0814s24
- Odhar, H. A., Ahjel, S. W., Albeer, A., Hashim, A. F., Rayshan, A. M., & Humadi, S. S. (2020). Molecular docking and dynamics simulation of FDA approved drugs with the main protease from 2019 novel coronavirus. Bioinformation, 16(3), 236–244. https://doi.org/https://doi.org/10.6026/97320630016236
- Oostenbrink, C., Villa, A., Mark, A. E., & van Gunsteren, W. F. (2004). A biomolecular force field based on the free enthalpy of hydration and solvation: The GROMOS force-field parameter sets 53A5 and 53A6. Journal of Computational Chemistry, 25(13), 1656–1676. https://doi.org/https://doi.org/10.1002/jcc.20090
- Osman, E. E. A., Toogood, P. L., & Neamati, N. (2020). COVID-19: Living through another pandemic. ACS Infectious Diseases, 6(7), 1548-1552. https://doi.org/https://doi.org/10.1021/acsinfecdis.0c00224
- Parrinello, M., & Rahman, A. (1981). Polymorphic transitions in single crystals: A new molecular dynamics method. Journal of Applied Physics, 52(12), 7182–7190. https://doi.org/https://doi.org/10.1063/1.328693
- Schuttelkopf, A. W., & van Aalten, D. M. (2004). PRODRG: A tool for high-throughput crystallography of protein-ligand complexes. Acta Crystallographica. Section D, Biological Crystallography, 60(Pt 8), 1355–1363. https://doi.org/https://doi.org/10.1107/S0907444904011679
- Spoto, S., Valeriani, E., Locorriere, L., Anguissola, G. B., Pantano, A. L., Terracciani, F., Riva, E., Ciccozzi, M., Costantino, S., & Angeletti, S. (2019). Influenza B virus infection complicated by life-threatening pericarditis: A unique case-report and literature review. BMC Infectious Diseases, 19(1), 40. https://doi.org/https://doi.org/10.1186/s12879-018-3606-7
- Sullivan, F., Daly, F., & Gagyor, I. (2016). Antiviral agents added to corticosteroids for early treatment of adults with acute idiopathic facial nerve paralysis (Bell Palsy). JAMA, 316(8), 874–875. https://doi.org/https://doi.org/10.1001/jama.2016.10160
- Tang, E., Chen, Y., & Luo, Y. (2014). Dexamethasone for the prevention of acute mountain sickness: Systematic review and meta-analysis. International Journal of Cardiology, 173(2), 133–138. https://doi.org/https://doi.org/10.1016/j.ijcard.2014.03.019
- Thaera, G. M., Wellik, K. E., Barrs, D. M., Dunckley, E. D., Wingerchuk, D. M., & Demaerschalk, B. M. (2010). Are corticosteroid and antiviral treatments effective for bell palsy? A critically appraised topic. The Neurologist, 16(2), 138–140. https://doi.org/https://doi.org/10.1097/NRL.0b013e3181d35775
- Thiel, V., Ivanov, K. A., Putics, Á., Hertzig, T., Schelle, B., Bayer, S., Weißbrich, B., Snijder, E. J., Rabenau, H., Doerr, H. W., Gorbalenya, A. E., & Ziebuhr, J. (2003). Mechanisms and enzymes involved in SARS coronavirus genome expression. The Journal of General Virology, 84(Pt 9), 2305–2315. https://doi.org/https://doi.org/10.1099/vir.0.19424-0
- Turner, M. T., Nayak, S., Kuhn, M., & Roehm, P. C. (2014). The effects of dexamethasone and acyclovir on a cell culture model of delayed facial palsy. Otology & Neurotology: Official Publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology, 35(4), 712–718. https://doi.org/https://doi.org/10.1097/MAO.0000000000000231
- Wheeler, C. E., Harvie, E. J., Jr., & Canby, C. M. (1961). The effect of hydrocortisone on the production of herpes simplex virus in tissue culture. The Journal of Investigative Dermatology, 36, 89–97. http://www.ncbi.nlm.nih.gov/pubmed/13784752 https://doi.org/https://doi.org/10.1038/jid.1961.18
- Wright, J. J., & O'Driscoll, G. (2005). Treatment of parainfluenza virus 3 pneumonia in a cardiac transplant recipient with intravenous ribavirin and methylprednisolone. The Journal of Heart and Lung Transplantation: The Official Publication of the International Society for Heart Transplantation, 24(3), 343–346. https://doi.org/https://doi.org/10.1016/j.healun.2004.01.003
- Wu, F., Zhao, S., Yu, B., Chen, Y. M., Wang, W., Song, Z. G., Hu, Y., Tao, Z. W., Tian, J. H., Pei, Y. Y., Yuan, M. L., Zhang, Y. L., Dai, F. H., Liu, Y., Wang, Q. M., Zheng, J. J., Xu, L., Holmes, E. C., & Zhang, Y. Z. (2020). A new coronavirus associated with human respiratory disease in China. Nature, 579(7798), 265–269. https://doi.org/https://doi.org/10.1038/s41586-020-2008-3
- Xue, H., Li, J., Xie, H., & Wang, Y. (2018). Review of drug repositioning approaches and resources. International Journal of Biological Sciences, 14(10), 1232–1244. https://doi.org/https://doi.org/10.7150/ijbs.24612
- Yan, L., Velikanov, M., Flook, P., Zheng, W., Szalma, S., & Kahn, S. (2003). Assessment of putative protein targets derived from the SARS genome. FEBS Letters, 554(3), 257–263. https://doi.org/https://doi.org/10.1016/S0014-5793(03)01115-3
- Yim, E. K., Lee, M. J., Lee, K. H., Um, S. J., & Park, J. S. (2006). Antiproliferative and antiviral mechanisms of ursolic acid and dexamethasone in cervical carcinoma cell lines. International Journal of Gynecological Cancer: Official Journal of the International Gynecological Cancer Society, 16(6), 2023–2031. https://doi.org/https://doi.org/10.1111/j.1525-1438.2006.00726.x
- Yoder, M. C., Jr., Chua, R., & Tepper, R. (1991). Effect of dexamethasone on pulmonary inflammation and pulmonary function of ventilator-dependent infants with bronchopulmonary dysplasia. The American Review of Respiratory Disease, 143(5 Pt 1), 1044–1048. https://doi.org/https://doi.org/10.1164/ajrccm/143.5_Pt_1.1044
- Yu, W. C., Hui, D. S., & Chan-Yeung, M. (2004). Antiviral agents and corticosteroids in the treatment of severe acute respiratory syndrome (SARS). Thorax, 59(8), 643–645. https://doi.org/https://doi.org/10.1136/thx.2003.017665
- Zhang, L., Lin, D., Sun, X., Curth, U., Drosten, C., Sauerhering, L., Becker, S., Rox, K., & Hilgenfeld, R. (2020). Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved alpha-ketoamide inhibitors. Science, 368(6489), 409–412. https://doi.org/https://doi.org/10.1126/science.abb3405
- Zheng, J. (2020). SARS-CoV-2: An emerging coronavirus that causes a global threat. International Journal of Biological Sciences, 16(10), 1678–1685. https://doi.org/https://doi.org/10.7150/ijbs.45053
- Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., Zhao, X., Huang, B., Shi, W., Lu, R., Niu, P., Zhan, F., Ma, X., Wang, D., Xu, W., Wu, G., Gao, G. F., Tan, W., China Novel Coronavirus, I., Research, T,… China Novel Coronavirus Investigating and Research Team (2020). A Novel Coronavirus from Patients with Pneumonia in China, 2019. The New England Journal of Medicine, 382(8), 727–733. https://doi.org/https://doi.org/10.1056/NEJMoa2001017